01/05/2026
๐ ๐๐ฅ๐๐ง๐ง๐ข๐ง๐ ๐๐จ๐ซ ๐๐๐๐ ๐๐ญ๐๐ซ๐ญ๐ฌ ๐ฐ๐ข๐ญ๐ก ๐๐ฆ๐๐ซ๐ญ๐๐ซ ๐๐ซ๐ฎ๐ ๐๐ญ๐ซ๐๐ญ๐๐ ๐ฒ
As rheumatology practices prepare for 2026, one reality is clear:
specialty drug costs, reimbursement pressure, and inventory complexity arenโt slowing down.
With specialty medications now representing ๐๐% of prescription drug spending and Medicare spending rising more than 560% over the last decade, drug purchasing strategy has become a defining factor in practice sustainability.
In our latest article, we explore how rheumatology-focused drug purchasing and management programs can help independent practices:
โ Reduce acquisition costs
โ Free up working capital
โ Improve inventory control
โ Strengthen performance in value-based care
โ Reduce administrative burden
At Articularis Healthcare Group, we help practices move into 2026 with confidence โ pairing competitive pricing with rheumatology-specific expertise and white-glove support.
๐ ๐๐ ๐๐๐๐ ๐ข๐ฌ ๐ญ๐ก๐ ๐ฒ๐๐๐ซ ๐ฒ๐จ๐ฎ ๐ฐ๐๐ง๐ญ ๐ฌ๐ญ๐ซ๐จ๐ง๐ ๐๐ซ ๐ฆ๐๐ซ๐ ๐ข๐ง๐ฌ ๐๐ง๐ ๐๐๐ฐ๐๐ซ ๐จ๐ฉ๐๐ซ๐๐ญ๐ข๐จ๐ง๐๐ฅ ๐ก๐๐๐๐๐๐ก๐๐ฌ, ๐ง๐จ๐ฐ ๐ข๐ฌ ๐ญ๐ก๐ ๐ญ๐ข๐ฆ๐ ๐ญ๐จ ๐๐๐ญ.
Explore how AHG can support your practice:
๐ https://articularishealthcare.com/news/the-benefits-of-drug-purchasing-and-management-programs-for-rheumatology-practices/